Table: Otsuka - 9-MTH group results
Table: Otsuka - 6-MTH group results
Brief: Otsuka and Lundbeck announce top-line results from two phase III clinical trials
Table: Otsuka -Q1 group results
Table: Otsuka -2016 parent results
Table: Otsuka -2016 group results
Table: Otsuka -9-MTH group results
Brief: Otsuka's 9-month group operating profit seen at about 28 bln yen - Nikkei
Table: Otsuka -6-MTH group results
Brief: Alkermes says U.S. District Court issued unambiguous opinion in favor of co, U.S. FDA - SEC filing
Brief: Otsuka Corp's group net profit apparently grew 9% for the January-June half of 2016 - Nikkei
New implant set to join fight against U.S. painkiller epidemic
Table: Otsuka -Q1 group results
Table: Otsuka -2015 parent results
Table: Otsuka -2015 group results
Table: Otsuka -9-MTH group results
Nexium, Advair led Medicare drug spending in 2013 -officials (updated)
Nexium, Advair led Medicare drug spending in 2013 - officials
Brief: EU agency backs Sanofi diabetes drug Toujeo plus medicines from Otsuka, Novartispproval in advanced non small cell lung cancer